QOF database

Home | News | Downloads
CAMROSE MEDICAL PARTNERSHIP

CAMROSE MEDICAL PARTNERSHIP

CAMROSE MEDICAL P/SHIP, ST ANDREWS CENTRE, BASINGSTOKE, HAMPSHIRE

HF 4

The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.

IndicatorYearNumeratorDenominatorRatioCentile
HF 4 2010 5 6 83.3%
HF 4 2011 7 7 100.0%
HF 4 2012 6 7 85.7%
HF 4 2013 3 4 75.0%
HF004 2014 1 1 100.0%
HF004 2015 1 1 100.0%
HF004 2016 8 9 88.9%
HF004 2017 5 6 83.3%
HF004 2018 6 7 85.7%